Celyad Oncology SA (CLYYF)
OTCMKTS · Delayed Price · Currency is USD
0.1500
-0.0300 (-16.67%)
At close: Dec 26, 2025
Celyad Oncology Employees
As of December 31, 2024, Celyad Oncology had 19 total employees, including 17 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$12,135
Profits / Employee
-$421,152
Market Cap
14.45M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 19 | 0 | - | 17 | 2 |
| Dec 31, 2023 | 19 | -19 | -50.00% | 17 | 2 |
| Dec 31, 2022 | 38 | -63 | -62.38% | 35 | 3 |
| Dec 31, 2021 | 101 | 10 | 10.99% | 95 | 6 |
| Dec 31, 2020 | 91 | -16 | -14.95% | 87 | 4 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| LakeShore Biopharma | 573 |
| HOOKIPA Pharma | 87 |
| NKGen Biotech | 26 |
| Inhibitor Therapeutics | 9 |
| AccuStem Sciences | 2 |
| Synlogic | 1 |